Xinfu Zhang

Xinfu Zhang

Auto-generated profile, based on publicly available information

Xinfu Zhang

State Key Laboratory of Fine Chemicals Frontiers Science Center for Smart Materials Oriented Chemical Engineering Dalian University of Technology Dalian China

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 January 2020 in Nature Nanotechnology
Verified
Journal Article
Closed access
PDF file
XHXucheng Hou
Xucheng Hou
XZXinfu Zhang
Xinfu Zhang
WZWeiyu Zhao
Weiyu Zhao
CZChunxi Zeng
Chunxi Zeng
BDBinbin Deng
Binbin Deng
YDYizhou Dong
Yizhou Dong

10 August 2020 in Nature Cancer
Verified
Journal Article
Closed access
PDF file
YLYingzhong Li
Yingzhong Li
ZSZhijun Su
Zhijun Su
WZWeiyu Zhao
Weiyu Zhao
XZXinfu Zhang
Xinfu Zhang
NMNoor Momin
Noor Momin
RWRon Weiss
Ron Weiss

22 April 2021 in Small
Verified
Journal Article
Closed access
PDF file
HBHui Bian
Hui Bian
DMDandan Ma
Dandan Ma
XZXinfu Zhang
Xinfu Zhang
KXKai Xin
Kai Xin
YYYoujun Yang
Youjun Yang
YXYi Xiao
Yi Xiao

21 August 2020 in Science Advances
Verified
Journal Article
Open access
PDF file
XZXinfu Zhang
Xinfu Zhang
WZWeiyu Zhao
Weiyu Zhao
GNGiang N. Nguyen
Giang N. Nguyen
CZChengxiang Zhang
Chengxiang Zhang
CZChunxi Zeng
Chunxi Zeng
YDYizhou Dong
Yizhou Dong
Biodegradable nanomaterials effectively deliver long messenger RNAs in animal models.

5 September 2018 in Chemical Science
Verified
Journal Article
Open access
PDF file
XZXinfu Zhang
Xinfu Zhang
WZWeiyu Zhao
Weiyu Zhao
BLBin Li
Bin Li
WLWenqing Li
Wenqing Li
CZChengxiang Zhang
Chengxiang Zhang
YDYizhou Dong
Yizhou Dong
Hypochlorous acid (HClO) is a promising diagnostic marker for inflammation and relevant diseases. Although many probes were previously developed for HClO imaging, the development of organ targeting probes is still lacking. Herein, we designed and synthesized a series of cyanine derivatives as ratiometric fluorescent probes to detect endogenous HClO in the lungs with inflammation. By installing diverse lipid chains and amino groups on cyanine, we identified that ClO1, with one n-octadecane chain and two 2-[[2-(dimethylamino)ethyl]methylamino]-ethyl groups, is a superior probe to target the lungs over other major organs in mice. ClO1 was able to sense both exogenous and endogenous HClO in A549 (human lung epithelial) cells through fluorescence ratiometric imaging. In a lipopolysaccharide (LPS)-induced lung inflammation mouse model, ClO1 effectively captured endogenous HClO in the lungs after intravenous administration. Overall, these cyanine-derived probes merit further development as organ targeting HClO sensors.

14 December 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
WLWenqing Li
Wenqing Li
XZXinfu Zhang
Xinfu Zhang
CZChengxiang Zhang
Chengxiang Zhang
JYJingyue Yan
Jingyue Yan
XHXucheng Hou
Xucheng Hou
YDYizhou Dong
Yizhou Dong
Antibodies targeting costimulatory receptors of T cells have been developed for the activation of T cell immunity in cancer immunotherapy. However, costimulatory molecule expression is often lacking in tumor-infiltrating immune cells, which can impede antibody-mediated immunotherapy. Here, we hypothesize that delivery of costimulatory receptor mRNA to tumor-infiltrating T cells will enhance the antitumor effects of antibodies. We first design a library of biomimetic nanoparticles and find that phospholipid nanoparticles (PL1) effectively deliver costimulatory receptor mRNA (CD137 or OX40) to T cells. Then, we demonstrate that the combination of PL1-OX40 mRNA and anti-OX40 antibody exhibits significantly improved antitumor activity compared to anti-OX40 antibody alone in multiple tumor models. This treatment regimen results in a 60% complete response rate in the A20 tumor model, with these mice being resistant to rechallenge by A20 tumor cells. Additionally, the combination of PL1-OX40 mRNA and anti-OX40 antibody significantly boosts the antitumor immune response to anti-PD-1 + anti-CTLA-4 antibodies in the B16F10 tumor model. This study supports the concept of delivering mRNA encoding costimulatory receptors in combination with the corresponding agonistic antibody as a strategy to enhance cancer immunotherapy.